An official website of the United States government
NIH Guide: Weekly Index for August 5, 2022
Weekly NIH Guide Notices
August 5, 2022
Policy Notices
-
Implementation Details for the NIH Data Management and Sharing Policy
(NOT-OD-22-189)National Institutes of Health
-
Adjustments to NIH and AHRQ Grant Application Due Dates Between September 22 and September 30, 2022
(NOT-OD-22-190)National Institutes of HealthAgency for Healthcare Research and Quality
General Notices
-
Notice of FY2023 Cohort Dates for PAR-22-073, Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
(NOT-CA-22-116)National Cancer Institute
-
Notice of Correction to PAR-22-187, NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
(NOT-CA-22-118)National Cancer Institute
-
Notice of Correction to PAR-22-188, NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
(NOT-CA-22-119)National Cancer Institute
-
Notice of Information Webinar for PAR-22-212 "Institutional Research and Academic Career Development Award (IRACDA) (K12)"
(NOT-GM-22-042)National Institute of General Medical Sciences
-
Notice of Upcoming Prize Competition Announcement for the RADx Tech for Maternal Health Challenge
(NOT-HD-22-035)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Information: National Institute on Minority Health and Health Disparities (NIMHD) Award to Morehouse School of Medicine Due to Congressional Earmark
(NOT-MD-22-024)National Institute on Minority Health and Health Disparities
Notice of Changes to Funding Opportunities
-
Notice of Change to add PA-20-195 in NOT-CA-21-121 "Notice of Special Interest (NOSI): Dietary Effects on Nutrient Sensing Pathways in Tumor Etiology and Prevention"
(NOT-CA-22-114)National Cancer Institute
-
Notice of Change to Foreign Eligibility and Application Due Date for RFA-HD-23-026 "NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional) "
(NOT-HD-22-032)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of NINR Participation in PAR-22-181, "NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
(NOT-NR-22-016)National Institute of Nursing ResearchNational Institute of Neurological Disorders and Stroke
-
Notice of Change to the title of PAR-22-181, "NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
(NOT-NS-22-111)National Institute of Neurological Disorders and StrokeNational Institute of Nursing Research
-
Notice of Correction to Award Conditions for NOT-NS-23-001: "Notice of Special Interest (NOSI): COVID-19 Related Revisions to NINDS ADRD Human Subjects Cooperative Agreement Programs"
(NOT-NS-23-020)National Institute of Neurological Disorders and Stroke
-
Notice of Correction for RFA-OD-22-015: Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed)
(NOT-OD-22-187)Office of Research on Women's Health
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
(NOT-CA-22-091)National Cancer Institute
Notices of Special Interest
-
Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation
(NOT-AI-22-056)National Institute of Allergy and Infectious DiseasesNational Institute of Mental Health
-
Notice of Special Interest (NOSI): HEAL Initiative: Opioid Use Disorder Care Pathways for Individuals with Histories of Exposure to Violence
(NOT-DA-23-007)National Institute on Drug AbuseEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthOffice of Behavioral and Social Sciences Research
-
Notice of Special Interest (NOSI) HEAL Initiative: Workforce Interventions to Improve Addiction Care Quality and Patient Outcomes
(NOT-DA-23-008)National Institute on Drug AbuseNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Center for Complementary and Integrative Health
-
Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech
(NOT-NS-23-002)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative Health
-
Notice of Special Interest (NOSI): Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities with a focus on addressing diverse representation in research on Down syndrome (R21 Clinical Trial Optional)
(NOT-OD-22-142)Office of the Director, NIHNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Institute of Neurological Disorders and StrokeNational Institute on Minority Health and Health Disparities
Funding Opportunities
-
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
(PAR-22-222)National Institute of Allergy and Infectious DiseasesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthApplication Receipt Date(s): December 7, 2024
-
Alzheimer's-related Resource Centers for Minority Aging Research (AD/ADRD RCMAR) (P30 Clinical Trial Optional)
(RFA-AG-23-025)National Institute on AgingApplication Receipt Date(s): October 21, 2022
-
Resource Centers for Minority Aging Research (RCMAR) (P30 Clinical Trial Optional)
(RFA-AG-23-026)National Institute on AgingApplication Receipt Date(s): October 21, 2022
-
Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (U24 Clinical Trial Optional)
(RFA-AG-23-027)National Institute on AgingApplication Receipt Date(s): October 21, 2022
-
Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional)
(RFA-CA-22-019)National Cancer InstituteNational Institute of Mental HealthApplication Receipt Date(s): November 8, 2022
-
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
(RFA-DA-23-053)National Institute on Drug AbuseNational Institute on AgingEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthApplication Receipt Date(s): December 16, 2024
-
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
(RFA-DA-23-054)National Institute on Drug AbuseNational Institute on AgingEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthApplication Receipt Date(s): December 16, 2024
-
Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (R61/R33 - Clinical Trial Not Allowed)
(RFA-DE-23-006)National Institute of Dental and Craniofacial ResearchApplication Receipt Date(s): November 9, 2022
-
Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (R42 Fast-Track - Clinical Trial Not Allowed)
(RFA-DE-23-007)National Institute of Dental and Craniofacial ResearchApplication Receipt Date(s): November 9, 2022
-
Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (Fast-Track - R44 - Clinical Trial Not Allowed)
(RFA-DE-23-008)National Institute of Dental and Craniofacial ResearchApplication Receipt Date(s): November 9, 2022
-
HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R01 Clinical Trial Not Allowed)
(RFA-DE-23-015)National Institute of Dental and Craniofacial ResearchNational Institute on Drug AbuseNational Center for Complementary and Integrative HealthApplication Receipt Date(s): February 14, 2023
-
HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R21 Clinical Trial Not Allowed)
(RFA-DE-23-016)National Institute of Dental and Craniofacial ResearchNational Institute on Drug AbuseNational Center for Complementary and Integrative HealthApplication Receipt Date(s): February 14, 2023
-
NICHD Global Network for Womens and Childrens Health Research: Research Units (UG1 Clinical Trial Optional)
(RFA-HD-23-008)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): November 29, 2022
-
NICHD Global Network for Womens and Childrens Health Research: Data Coordinating Center (U24 Clinical Trial Optional)
(RFA-HD-23-009)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): November 29, 2022
-
Contraceptive Development Research Center (P50 Clinical Trial Optional)
(RFA-HD-23-029)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): December 01, 2022
-
Early-Stage Therapy Development for ADRD (R61/R33 Clinical Trial Not Allowed)
(RFA-NS-22-059)National Institute of Neurological Disorders and StrokeNational Institute on AgingApplication Receipt Date(s): October 31, 2022
-
HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional)
(RFA-NS-23-003)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Center for Complementary and Integrative HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)
(RFA-OD-22-014)Office of Research on Women's HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Drug AbuseNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthApplication Receipt Date(s): Multiple dates, see announcement.
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster